Lingling Hu

Lingling Hu

Auto-generated profile, based on publicly available information

Lingling Hu

Department of Spine Surgery, Hospital for Special Surgery, New York, NY

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2023 in Nature
Verified
Journal Article
Closed access
PDF file
JSJun Sun
Jun Sun
LHLingling Hu
Lingling Hu
SBSeoyeon Bok
Seoyeon Bok
AYAlisha R. Yallowitz
Alisha R. Yallowitz
MCMichelle Cung
Michelle Cung
MGMatthew B. Greenblatt
Matthew B. Greenblatt

20 September 2023 in Nature
Verified
Journal Article
Closed access
PDF file
SBSeoyeon Bok
Seoyeon Bok
AYAlisha R. Yallowitz
Alisha R. Yallowitz
JSJun Sun
Jun Sun
JMJason McCormick
Jason McCormick
MCMichelle Cung
Michelle Cung
MGMatthew B. Greenblatt
Matthew B. Greenblatt

1 August 2016 in Fungal Genetics and Biology
Verified
Journal Article
Closed access
LHLingling Hu
Lingling Hu
FYFan Yao
Fan Yao
YMYan Ma
Yan Ma
QLQiannan Liu
Qiannan Liu
SCSi Chen
Si Chen
YFYue Fang
Yue Fang

9 January 2024 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
KMKyle W. Morse
Kyle W. Morse
JSJun Sun
Jun Sun
LHLingling Hu
Lingling Hu
SBSeoyeon Bok
Seoyeon Bok
SDShawon Debnath
Shawon Debnath
MGMatthew B. Greenblatt
Matthew B. Greenblatt
Background: Multiple animal models have previously been utilized to investigate anterior fusion techniques, but a mouse model has yet to be developed. The purpose of this study was to develop murine anterior interbody and posterolateral fusion techniques. Methods: Mice underwent either anterior interbody or posterolateral spinal fusion. A protocol was developed for both procedures, including a description of the relevant anatomy. Samples were subjected to micro-computed tomography to assess fusion success and underwent biomechanical testing with use of 4-point bending. Lastly, samples were fixed and embedded for histologic evaluation. Results: Surgical techniques for anterior interbody and posterolateral fusion were developed. The fusion rate was 83.3% in the anterior interbody model and 100% in the posterolateral model. Compared with a control, the posterolateral model exhibited a greater elastic modulus. Histologic analysis demonstrated endochondral ossification between bridging segments, further confirming the fusion efficacy in both models. Conclusions: The murine anterior interbody and posterolateral fusion models are efficacious and provide an ideal platform for studying the molecular and cellular mechanisms mediating spinal fusion. Clinical Relevance: Given the extensive genetic tools available in murine disease models, use of fusion models such as ours can enable determination of the underlying genetic pathways involved in spinal fusion.

24 August 2017 in Sleep and Biological Rhythms
Verified
Journal Article
Closed access
PDF file
HWHanqing Wang
Hanqing Wang
PZPan Zhuge
Pan Zhuge
YJYuying Jiang
Yuying Jiang
KSKefeng Shao
Kefeng Shao
LHLingling Hu
Lingling Hu
GFGuofei Feng
Guofei Feng

3 April 2023
Verified
Other
Open access
SLShreyas Lingadahalli
Shreyas Lingadahalli
SJSudhir Jadhao
Sudhir Jadhao
YSYing Ying Sung
Ying Ying Sung
MCMi Chen
Mi Chen
LHLingling Hu
Lingling Hu
ECEdwin Cheung
Edwin Cheung
S1. The relative expression of KLK3/PSA. S2. Kaplan-Meier analysis of prostate cancer outcome was obtained from GEPIA tool. S3. LNCaP cells with the indicated treatments were seeded in the upper chamber of the Boyden's transwell chamber. S4. LNCaP cells with the indicated treatments were seeded in the upper chamber of the Boyden's transwell chamber which were coated with 1:20 diluted Matrigel. S5. LNCaP cells with the indicated treatments were seeded in the upper chamber of the Boyden's transwell chamber. S6. Snapshots form the AR ChIP-seq showing AR binding to the ARBS. S7. Screenshot from the AR ChIP-seq shows marked reduction in AR binding to the ARBS located at ~ 30kb from the NDRG1 after LINC00844 knock-down in LNCaP cells. S8. LNCaP cells with the indicated treatments were seeded in the upper chamber of the Boyden's transwell chamber. S9. LNCaP cells we co-transfected with the with the indicated siRNA and plasmids and seeded in the upper chamber of the Boyden's transwell chamber. S10. LNCaP cells we co-transfected with the with the indicated siRNA and plasmids cells were harvested and the required amount of cells were used for the migration and invasion assay and rest were lysed for western blot analysis.